Literature DB >> 31874171

Substrates, inhibitors, and probes of mammalian transglutaminase 2.

Ruize Zhuang1, Chaitan Khosla2.   

Abstract

Transglutaminase 2 (TG2) is a ubiquitous but enigmatic mammalian protein to which a number of biological functions have been ascribed but not definitively proven. As a member of the transglutaminase family, TG2 can catalyze deamidation or alternatively transamidation of selected Gln residues in proteins and peptides. It is also known to harbor other enzymatic properties, including protein disulfide isomerase, GTP-dependent signal transduction, and ATP dependent protein kinase activity. Given its multifunctional chemistry, it is unsurprising that a long list of proteins from the mammalian proteome have been identified as substrates and/or binding partners; however, the biological relevance of none of these protein-protein interactions has been clarified as yet. Remarkably, the most definitive insights into the biology of TG2 stem from its pathophysiological role in gluten peptide deamidation in celiac disease. Meanwhile our understanding of TG2 chemistry has been leveraged to engineer a spectrum of inhibitors and other molecular probes of TG2 biology in vivo. This review summarizes our current knowledge of the enzymology and regulation of human TG2 with a focus on its physiological substrates as well as tool molecules whose engineering was inspired by their identities.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chemical biology; Post-translational modifications; Transglutaminase

Year:  2019        PMID: 31874171      PMCID: PMC6948143          DOI: 10.1016/j.ab.2019.113560

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  60 in total

1.  Identification of preferred substrate sequences of microbial transglutaminase from Streptomyces mobaraensis using a phage-displayed peptide library.

Authors:  Yoshiaki Sugimura; Keiichi Yokoyama; Noriki Nio; Masatoshi Maki; Kiyotaka Hitomi
Journal:  Arch Biochem Biophys       Date:  2008-06-24       Impact factor: 4.013

Review 2.  Transdab wiki: the interactive transglutaminase substrate database on web 2.0 surface.

Authors:  Eva Csosz; Bertalan Meskó; László Fésüs
Journal:  Amino Acids       Date:  2008-07-02       Impact factor: 3.520

3.  Proteomics. Tissue-based map of the human proteome.

Authors:  Mathias Uhlén; Linn Fagerberg; Björn M Hallström; Cecilia Lindskog; Per Oksvold; Adil Mardinoglu; Åsa Sivertsson; Caroline Kampf; Evelina Sjöstedt; Anna Asplund; IngMarie Olsson; Karolina Edlund; Emma Lundberg; Sanjay Navani; Cristina Al-Khalili Szigyarto; Jacob Odeberg; Dijana Djureinovic; Jenny Ottosson Takanen; Sophia Hober; Tove Alm; Per-Henrik Edqvist; Holger Berling; Hanna Tegel; Jan Mulder; Johan Rockberg; Peter Nilsson; Jochen M Schwenk; Marica Hamsten; Kalle von Feilitzen; Mattias Forsberg; Lukas Persson; Fredric Johansson; Martin Zwahlen; Gunnar von Heijne; Jens Nielsen; Fredrik Pontén
Journal:  Science       Date:  2015-01-23       Impact factor: 47.728

4.  Redox regulation of transglutaminase 2 activity.

Authors:  Jorunn Stamnaes; Daniel M Pinkas; Burkhard Fleckenstein; Chaitan Khosla; Ludvig M Sollid
Journal:  J Biol Chem       Date:  2010-06-14       Impact factor: 5.157

5.  Structure-activity relationship study of novel tissue transglutaminase inhibitors.

Authors:  Eric Duval; April Case; Ross L Stein; Gregory D Cuny
Journal:  Bioorg Med Chem Lett       Date:  2005-04-01       Impact factor: 2.823

6.  Transglutaminase-sensitive glutamine residues of human plasma fibronectin revealed by studying its proteolytic fragments.

Authors:  L Fesus; M L Metsis; L Muszbek; V E Koteliansky
Journal:  Eur J Biochem       Date:  1986-01-15

7.  Glutamine (Q)-peptide screening for transglutaminase reaction using mRNA display.

Authors:  Jae-Hun Lee; Changhyeon Song; Do-Hyun Kim; Il-Hyang Park; Sun-Gu Lee; Yoon-Sik Lee; Byung-Gee Kim
Journal:  Biotechnol Bioeng       Date:  2012-08-17       Impact factor: 4.530

8.  Transglutaminase 2 as a cisplatin resistance marker in non-small cell lung cancer.

Authors:  Kang-Seo Park; Hyun-Kyoung Kim; Jung-Hwa Lee; Yong-Bock Choi; Seong-Yeol Park; Sei-Hoon Yang; Soo-Youl Kim; Kyeong-Man Hong
Journal:  J Cancer Res Clin Oncol       Date:  2009-09-18       Impact factor: 4.553

9.  Unconventional secretion of tissue transglutaminase involves phospholipid-dependent delivery into recycling endosomes.

Authors:  Evgeny A Zemskov; Irina Mikhailenko; Ru-Ching Hsia; Liubov Zaritskaya; Alexey M Belkin
Journal:  PLoS One       Date:  2011-04-27       Impact factor: 3.240

10.  Crystal structure of transglutaminase 2 with GTP complex and amino acid sequence evidence of evolution of GTP binding site.

Authors:  Tae-Ho Jang; Dong-Sup Lee; Kihang Choi; Eui Man Jeong; In-Gyu Kim; Young Whan Kim; Jung Nyeo Chun; Ju-Hong Jeon; Hyun Ho Park
Journal:  PLoS One       Date:  2014-09-05       Impact factor: 3.240

View more
  8 in total

Review 1.  Structures of Human Transglutaminase 2: Finding Clues for Interference in Cross-linking Mediated Activity.

Authors:  Gi Eob Kim; Hyun Ho Park
Journal:  Int J Mol Sci       Date:  2020-03-23       Impact factor: 5.923

2.  Transglutaminase 2 crosslinks the glutathione S-transferase tag, impeding protein-protein interactions of the fused protein.

Authors:  Hyo-Jun Kim; Jin-Haeng Lee; Ki Baek Lee; Ji-Woong Shin; Mee-Ae Kwon; Soojin Lee; Eui Man Jeong; Sung-Yup Cho; In-Gyu Kim
Journal:  Exp Mol Med       Date:  2021-01-13       Impact factor: 8.718

3.  Transglutaminase 2 moderates the expansion of mouse abdominal aortic aneurysms.

Authors:  Kathryn J Griffin; Kingsley R Simpson; Cora M L Beckers; Laura M Newell; Lih T Cheah; Nadira Y Yuldasheva; Siiri Iismaa; Christopher L Jackson; Julian D A Scott; Richard J Pease
Journal:  JVS Vasc Sci       Date:  2021-05-18

Review 4.  Exploring the Role of Transglutaminase in Patients with Glioblastoma: Current Perspectives.

Authors:  William P Katt; Cody Aplin; Richard A Cerione
Journal:  Onco Targets Ther       Date:  2022-03-19       Impact factor: 4.147

Review 5.  Type 2 Transglutaminase in Coeliac Disease: A Key Player in Pathogenesis, Diagnosis and Therapy.

Authors:  Gaetana Paolella; Silvia Sposito; Antonio Massimiliano Romanelli; Ivana Caputo
Journal:  Int J Mol Sci       Date:  2022-07-06       Impact factor: 6.208

6.  The temperature and pH repertoire of the transglutaminase family is expanding.

Authors:  Aaron Lerner; Ajay Ramesh; Torsten Matthias
Journal:  FEBS Open Bio       Date:  2020-04       Impact factor: 2.693

7.  Polyamine Oxidase Is Involved in Spermidine Reduction of Transglutaminase Type 2-Catalyzed βH-Crystallins Polymerization in Calcium-Induced Experimental Cataract.

Authors:  Carlo Mischiati; Giordana Feriotto; Claudio Tabolacci; Fabio Domenici; Sonia Melino; Ilaria Borromeo; Cinzia Forni; Angelo De Martino; Simone Beninati
Journal:  Int J Mol Sci       Date:  2020-07-30       Impact factor: 5.923

Review 8.  Dietary Gluten and Neurodegeneration: A Case for Preclinical Studies.

Authors:  Mahesh Mohan; Chioma M Okeoma; Karol Sestak
Journal:  Int J Mol Sci       Date:  2020-07-29       Impact factor: 6.208

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.